CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 48 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 4.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,006,369 | +4.5% | 2,937,615 | 0.0% | 42.74% | +37.8% |
Q2 2023 | $18,183,837 | +60.8% | 2,937,615 | 0.0% | 31.01% | +37.4% |
Q1 2023 | $11,309,818 | +24.2% | 2,937,615 | 0.0% | 22.57% | +51.8% |
Q4 2022 | $9,106,607 | -22.9% | 2,937,615 | 0.0% | 14.87% | -19.2% |
Q3 2022 | $11,809,000 | -17.5% | 2,937,615 | 0.0% | 18.39% | -6.6% |
Q2 2022 | $14,306,000 | -45.7% | 2,937,615 | 0.0% | 19.69% | -1.9% |
Q1 2022 | $26,350,000 | -0.1% | 2,937,615 | +25.4% | 20.06% | +68.8% |
Q4 2021 | $26,370,000 | – | 2,341,891 | – | 11.89% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 3,931,818 | $31,297,271 | 37.26% |